EMA Authorised: Coagadex (human coagulation factor X) — Kedrion S.p.A.

View source ↗

Summary

EMA authorised Coagadex, a human coagulation factor X concentrate, for the treatment of Factor X deficiency. The product, developed by Kedrion S.p.A., received …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Factor Deficiency

Drugs mentioned

• Coagadex (Factor X concentrate)

Snippet

Status: Authorised. Therapeutic area: Factor X Deficiency. MAH: Kedrion S.p.A.. Decision date: 21/11/2025. Orphan medicine. Accelerated assessment